IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)
Victor J. van den Berg, Dorian O. Haskard, Artur Fedorowski, Adam Hartley, Isabella Kardys, Mikhail Caga-Anan, K. Martijn Akkerhuis, Rohit M. Oemrawsingh, Robert‐Jan van Geuns, Peter de Jaegere, Nicolas M. Van Mieghem, Evelyn Regar, Jürgen Ligthart, Victor A. Umans, Patrick W. Serruys, Olle Melander, Eric Boersma, Ramzi Khamis (2018). IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3). EBioMedicine, 36, pp. 63-72, DOI: 10.1016/j.ebiom.2018.08.023.
